G Mariani

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With <i>KRAS</i>-Mutant Advanced Non–Small Cell Lung Cancer

Pasi A. Jänne, Michel M. van den Heuvel, Fabrice Barlési et al. · JAMA · 2017 · 332 citations · Full text

Medicine, Oncology, Pharmacology +17

Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells

Robert H. Vonderheide, Patricia LoRusso, Magi Khalil et al. · Clinical Cancer Research · 2010 · 302 citations

Medicine, Oncology, Pharmacology +17

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Richard D. Carvajal, Sophie Piperno‐Neumann, Ellen Kapiteijn et al. · Journal of Clinical Oncology · 2018 · 275 citations · Full text

Medicine, Oncology, Pharmacology +15

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer

Andrea Ardizzoni, M. Venturini, M.R. Sertoli et al. · British Journal of Cancer · 1994 · 70 citations · Full text

Medicine, Oncology, Breast Oncology +13

Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial

Carlo Salvarani, Marco Massari, Massimo Costantini et al. · European Respiratory Journal · 2022 · 61 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15